Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease

Published:2014-07-05 Issue:3 Volume:35 Page:979-985
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Goh George B¹,Pagadala Mangesh R¹,Dasarathy Jaividhya²,Unalp-Arida Aynur³,Sargent Ruth¹,Hawkins Carol⁴,Sourianarayanane Achuthan¹,Khiyami Amer⁵,Yerian Lisa⁶,Pai Rish⁶,McCullough Arthur J¹⁷,Dasarathy Srinivasan¹⁷

Affiliation:

1. Department of Gastroenterology; Cleveland Clinic; Cleveland OH USA

2. Department of Family Medicine; MetroHealth Medical Center; Cleveland OH USA

3. Department of Public Health; Johns Hopkins University; Baltimore MD USA

4. Department of Gastroenterology; MetroHealth Medical Center; Cleveland OH USA

5. Department of Pathology; MetroHealth Medical Center; Cleveland OH USA

6. Department of Pathology; Cleveland Clinic; Cleveland OH USA

7. Department of Pathobiology; Cleveland Clinic; Cleveland OH USA

Funder

Singapore SingHealth HMDP

NIH

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12611/fullpdf

Reference48 articles.

1. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

2. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference;Neuschwander-Tetri;Hepatology,2003

3. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

4. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States;Charlton;Gastroenterology,2011

5. The role of the renin-angiotensin system in liver fibrosis;Munshi;Exp Biol Med,2011

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic-associated fatty liver disease and the role of hormones in its aetiopathogenesis;Endokrynologia Polska;2024-06-26

2. Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications?;World Journal of Gastroenterology;2024-05-14

3. The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases;Hormone and Metabolic Research;2024-03-12

4. The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease;Antioxidants;2024-01-10

5. New-onset age of metabolic-associated fatty liver disease and incident cardiovascular diseases: Findings from prospective cohort;The Innovation Medicine;2024